Xencor

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Xencor Inc

Press Releases

Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease

Xencor Reports Third Quarter 2024 Financial Results

Xencor to Participate at Upcoming Investor Conferences

Xencor Reports Fourth Quarter and Full Year 2024 Financial Results

Xencor Appoints Todd Simpson to Board of Directors

Xencor Announces Positive Interim Results From First-in-Human Healthy Volunteer Study of XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, in Development for Treatment of Inflammatory Bowel Disease

Xencor Reports First Quarter 2025 Financial Results

Xencor Appoints Raymond Deshaies, Ph.D., to Board of Directors

Xencor Reports Second Quarter 2025 Financial Results

XNCR

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma

Akebia Therapeutics

AnaptysBio

ArriVent BioPharma

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

BridgeBio Oncology Therapeutics, Inc. - Common Stock

BridgeBio Oncology

Bicara Therapeutics

CareDx

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Geron

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

Inventiva S.A. - American Depository Shares

Inventiva

Kura Oncology

Nanobiotix

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Oruka Therapeutics

Relay Therapeutics

Rezolute

Spyre Therapeutics

Tango Therapeutics

Tyra Biosciences

UroGen Pharma

Valneva

Vir Biotechnology

Zenas BioPharma

Barclays

B of A Securities

Wedbush

RBC Capital

Wells Fargo

Comments

Xencor

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO